Anti-cancer therapy comprising an H2-blocker, at least one antiinflammatory agent and a cytotoxic agent

Details for Australian Patent Application No. 2007270686 (hide)

Owner TILTAN PHARMA LTD

Inventors Ben-Sasson, Shmuel A.

Agent Collison & Co

Pub. Number AU-B-2007270686

PCT Pub. Number WO2008/004231

Priority 60/880,107 12.01.07 US; 60/819,164 07.07.06 US

Filing date 4 July 2007

Wipo publication date 10 January 2008

Acceptance publication date 26 May 2011

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 31/196 (2006.01)

A61K 31/203 (2006.01)

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/425 (2006.01) - Thiazoles

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

12 February 2009 PCT application entered the National Phase

  PCT publication WO2008/004231 Priority application(s): WO2008/004231

26 May 2011 Application Accepted

  Published as AU-B-2007270686

22 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007270693-Collecting sheath and method of use thereof

2007270684-Mixing apparatus